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Single-molecule analysis of subtelomeres
and telomeres in Alternative Lengthening
of Telomeres (ALT) cells
Heba Z. Abid1, Jennifer McCaffrey1, Kaitlin Raseley1, Eleanor Young1, Katy Lassahn2, Dharma Varapula1,
Harold Riethman2* and Ming Xiao1,3*
Abstract
Background: Telomeric DNA is typically comprised of G-rich tandem repeat motifs and maintained by telomerase (Greider
CW, Blackburn EH; Cell 51:887–898; 1987). In eukaryotes lacking telomerase, a variety of DNA repair and DNA recombination
based pathways for telomere maintenance have evolved in organisms normally dependent upon telomerase for telomere
elongation (Webb CJ, Wu Y, Zakian VA; Cold Spring Harb Perspect Biol 5:a012666; 2013); collectively called Alternative
Lengthening of Telomeres (ALT) pathways. By measuring (TTAGGG) n tract lengths from the same large DNA molecules that
were optically mapped, we simultaneously analyzed telomere length dynamics and subtelomere-linked structural changes
at a large number of specific subtelomeric loci in the ALT-positive cell lines U2OS, SK-MEL-2 and Saos-2.
Results: Our results revealed loci-specific ALT telomere features. For example, while each subtelomere included examples of
single molecules with terminal (TTAGGG) n tracts as well as examples of recombinant telomeric single molecules, the ratio
of these molecules was subtelomere-specific, ranging from 33:1 (19p) to 1:25 (19q) in U2OS. The Saos-2 cell line shows a
similar percentage of recombinant telomeres. The frequency of recombinant subtelomeres of SK-MEL-2 (11%) is about half
that of U2OS and Saos-2 (24 and 19% respectively). Terminal (TTAGGG) n tract lengths and heterogeneity levels, the
frequencies of telomere signal-free ends, and the frequency and size of retained internal telomere-like sequences (ITSs) at
recombinant telomere fusion junctions all varied according to the specific subtelomere involved in a particular cell line. Very
large linear extrachromosomal telomere repeat (ECTR) DNA molecules were found in all three cell lines; these are in principle
capable of templating synthesis of new long telomere tracts via break-induced repair (BIR) long-tract DNA synthesis
mechanisms and contributing to the very long telomere tract length and heterogeneity characteristic of ALT cells. Many of
longest telomere tracts (both end-telomeres and linear ECTRs) displayed punctate CRISPR/Cas9-dependent (TTAGGG) n
labeling patterns indicative of interspersion of stretches of non-canonical telomere repeats.
Conclusion: Identifying individual subtelomeres and characterizing linked telomere (TTAGGG) n tract lengths and structural
changes using our new single-molecule methodologies reveals the structural consequences of telomere damage, repair and
recombination mechanisms in human ALT cells in unprecedented molecular detail and significant differences in different
ALT-positive cell lines.
Keywords: Genomics, Cancer telomeres, Alternative lengthening of telomeres (ALT), U2OS, SK-MEL-2, Saos-2, Single
molecule optical mapping
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Telomeres are nucleoprotein structures located at the
tips of eukaryotic chromosomes that prevent the ends of
the linear DNA component of chromosomes from being
recognized and processed as double-strand breaks, and
which provide a means for the faithful completion of
chromosomal DNA replication [1, 2]. Telomeric DNA is
typically comprised of G-rich tandem repeat motifs; the
precise sequence of the telomeric DNA motif is deter-
mined by the species-dependent RNA component of the
RNP enzyme telomerase. Telomerase adds DNA copies
of this motif to existing telomeric DNA at chromosome
ends [3]. In eukaryotes lacking telomerase, telomeres
can be maintained via the activity of retrotransposons
[4] and in some cases by epigenetically regulated protec-
tion of DNA ends not ordinarily considered telomeric
[5, 6]. A variety of DNA repair and DNA recombination
based pathways for telomere maintenance have evolved
in organisms normally dependent upon telomerase for
telomere elongation [1]; collectively called Alternative
Lengthening of Telomeres (ALT) pathways, they can be-
come activated or up-regulated in the absence of tel-
omerase activity.
Human telomeric DNA is comprised of 5’TTAGGG3’
motifs [7]. Most human somatic tissues do not contain
an active telomere maintenance mechanism, which re-
sults in the loss of telomere repeats with each somatic
cell division due to the “end replication problem” as well
as telomeric DNA end processing [7, 8]. The telomere
nucleoprotein structure breaks down when telomeric
DNA tracts become critically short, causing telomere
dysfunction-mediated senescence or apoptosis [9–12] or,
in the absence of functional DNA Damage Response
(DDR) checkpoint pathways, aberrant telomeric DNA
repair, telomere fusions, and ongoing genome instability
[13]. In human cancer cells, telomere maintenance path-
ways have become re-activated, stabilizing the cancer
genome and enabling unlimited cellular proliferation.
While most cancers have an activated telomerase path-
way for maintaining telomeres [14], a significant number
(about 10–15%) lack telomerase and maintain their telo-
meres using ALT mechanisms [8].
ALT is most prevalent in specific cancer types, includ-
ing osteosarcoma and glioblastoma and are usually asso-
ciated with a poor prognosis [8, 15]. Human ALT has
long been hypothesized to involve double strand break
induced homologous recombination (HR) mechanisms
[16]. This is supported by evidence that genes encoding
HR proteins are necessary for telomere-length mainten-
ance in human ALT cells. Also, circumstantial evidence
has been provided in ALT cells that many HR proteins
are present with telomeric DNA and telomere-binding
proteins in promyelocytic leukemia (PML) bodies called
ALT-associated PML bodies (APBs), where multiple
ALT telomeres can cluster and exchange DNA via HR-
dependent mechanisms [8, 15]. ALT probably includes
strand invasion of the template molecule and formation
of an HR intermediate structure [8, 17]. Several pheno-
typic characteristics of ALT cells differentiate them from
telomerase-positive cancer cells. ALT cells have highly het-
erogeneous chromosomal telomere lengths that range from
undetectable to extremely long and these lengths can rap-
idly change [8]. Visualization of telomeres in ALT cell pop-
ulations with fluorescence in situ hybridization (FISH) has
confirmed this characteristic. One study showed that within
one cell, some chromosome ends had no detectable telo-
meric sequences while others had very strong telomere sig-
nals indicating extremely long telomere tracts [18] or
spatially clustered telomeres prone to homologous recom-
bination [19, 20]. Associated with greatly elevated levels of
recombination at telomeres in ALT cells are an abundance
of telomeric DNA that is separate from chromosomes. The
extrachromosomal telomeric DNA is either double-
stranded telomeric circles (t-circles), single- stranded circles
(either C-circles or G-circles depending on the DNA strand
of origin), linear double-stranded DNA, or “t-complex”
DNA that is most likely a highly branched structure [8].
Recent work suggests that ALT is a highly regulated telo-
mere repair pathway [21]. Telomere DNA damage caused
by TERRA transcription-induced R-loops within (TTAG
GG) n tracts [22, 23], dysfunctional ATRX [24, 25], and
replication stalling at telomeres [26] initiates DS break-
dependent homology directed repair (Break-induced Repair
(BIR)) synthesis of long telomere tracts [27, 28]; this telo-
mere lengthening repair mechanism is counteracted by
BLM/SLX-mediated HR processing steps [21] and active
telomere trimming mediated by TZAP [29, 30]. Multiple
non-canonical as well as classical DNA repair pathways ap-
pear to be active at ALT telomeres [31]. In order to help
decipher these mechanisms and their consequences for
ALT cancers, it is critical to characterize the telomere-
associated DNA structures at ALT telomeres in these cells
at the highest resolution possible. We have utilized our
recently-developed single-molecule method that simultan-
eously measures individual telomere (TTAGGG) n tract
lengths and identifies their physically linked DNA to
analyze these structures in the telomerase-negative ALT-
positive U2OS human osteosarcoma cancer cell line, SK-
MEL-2 melanoma cell line and Saos-2 osteosarcoma cell
line. We describe patterns of telomere (TTAGGG) n tracts
associated with specific subtelomeres, revealing multiple
types of telomeric DNA structures associated with DNA re-
pair events in ALT-positive cells and providing unique in-
sights into ALT.
Results
Our recently developed two-color labeling scheme was
performed on U2OS, SK-MEL-2 and Saos-2 genomic
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DNA to acquire global subtelomere-specific single-
telomere lengths [32] and associated subtelomere-
specific single-molecule structural data. Telomere
(TTAGGG) n tracts were specifically labeled with fluor-
escent dyes by CRISPR-Cas9 nick labeling. The telomere
labeling intensity is used to estimate the telomere
(TTAGGG) n tract length [32]. Simultaneously, the gen-
omic DNA is globally nick-labeled using Nt.BspQI to
target the GCTCTTC motif. The labeled DNA mole-
cules are then optically imaged in a high-throughput
manner using nanochannel arrays [33]. De novo assem-
bly of optically mapped, large single DNA fragments of
genomic DNA is performed and unique Nt.BspQI pat-
terns are used to map assemblies to subtelomeric refer-
ence sequences (human hg38), which allows for
identification of the specific subtelomeres, quantitation
of the linked single telomere (TTAGGG) n tract lengths,
and detection of recombinant single molecules contain-
ing intact subtelomeres [34–36].
Globally, we measured and analyzed an average of 30
out of 46 subtelomeres with approximately 30 molecules
per chromosome arm (Tables 1, 2 and 3). The chromo-
some arms 13p, 14p, 15p, 21p, 22p, XpYp could not be
identified and measured due to the lack of reference se-
quences or many gaps in the reference (indicated as nr
in Tables 1, 2 and 3). Chromosome arms 16p, 17p, and
22q subtelomeres failed the assembly with most samples
because of inverted nick pair (INP) sites in the subtelomere
[35] . These are two closely spaced nicking enzyme sites on
opposite strands which causes double-stranded breaks in
molecules to be mapped, precluding their assembly and
localization to the reference sequence. Several subtelo-
meres (4q, 10p, 10q and XqYq in U2OS 4q; 5p, and 11p in
SK-MEL; 2q, 7p, 8p, 9q, 11q, 12q, 15q, 20q and XqYq in
Saos-2 indicated as N/A in Tables 1, 2 and 3) did not have
enough assembled molecules for analysis; we believe the
most likely explanation for this are high levels of recom-
bination within these subtelomeres that would interfere
with assembly of consensus maps, although there are
other possible explanations (see discussion). The linked
telomere (TTAGGG) n tract length data and
subtelomere-associated structural data for each of these
subtelomeres is summarized in Tables 1, 2 and 3.
For all the subtelomeres analyzed, specific examples of
linked terminal (TTAGGG) n tract end fragments as
well as recombinant end fragments were found. Average
subtelomere-specific terminal (TTAGGG) n tract
lengths, the ratio of terminal end fragments to recom-
bined end fragments, as well as other telomere-
associated structural features varied widely depending
upon the specific subtelomere.
The majority of analyzed subtelomeres have mostly
terminal (TTAGGG) n ends and less than 50% recom-
binant ends. The exceptions to this rule were 1q, 3q, 7p,
8q, 11p 18q,19q and 21q of U2OS; 3q and 20q of SK-
MEL-2; and 1p, 3q, 8q,17q and 21q of Saos-2, each with
with over 50% recombinant telomeres. The longest
(TTAGGG) n tracts measured were mostly from ter-
minal telomere ends. In Fig. 1a, examples of individual
molecules for 2q (U2OS), 2p (SK-MEL-2) and 3p (Saos-
2) are shown with average telomere (TTAGGG) n
lengths of 5.5 ± 6.1 kb, 3.1 ± 4.1 kb, and 7.5 ± 5.5 kb re-
spectively. Within the singe molecule datasets corre-
sponding to each subtelomere, (TTAGGG) n tract
lengths are highly variable. A good example of this is
chromosome arm 2q of U2OS shown in Fig. 1a. One
molecule has a telomere length of 17.3 kb compared to
another molecule with a telomere length of 0.15 kb.
Likewise, differing telomere lengths are also seen in mol-
ecules from arm 2p of SK-MEL-2 and arm 3p from
Saos-2. The end (TTAGGG) n tract length distribution
is highly heterogeneous as indicated by the high stand-
ard deviation (Tables 1, 2 and 3). The high variability of
end (TTAGGG) n tract lengths observed here is a
known characteristic of the ALT mechanism of main-
taining telomere lengths [8], and our data show this
length heterogeneity extends to all of the specific subte-
lomeres ending in (TTAGGG) n tracts.
Among these arms with primarily end telomeres, we
do see examples of recombinant molecules that often re-
sult in internal telomere-like (TTAGGG) n sequence
tracts (ITSs; Tables 1, 2 and 3). The ITS length among
this group of recombinant molecules is also variable. For
example, recombinant telomeres at 1p, 5p, and 11q of
U2OS have short ITSs but at 12p there is a high fre-
quency of ITS absence at the recombined telomeres. All
12 recombinant molecules of the 5p end and 5 recom-
binant molecules of the 11q end have extremely short
ITSs of less than 500 bp in length. The three analyzed
examples of recombinant 5q ends have longer ITSs with
an average telomere length of 6.6 kb ± 3.6; an example is
shown in Fig. 1b. By contrast to U2OS, Saos-2 has fewer
detected ITS, which concentrated in a few arms.. The
SK-MEL-2 has fewest number of ITS.
We unexpectedly observed a very high level of signal-
free telomere ends in these three cell lines. A total of 57
out of 781 ends completely lacked detectable (TTAG
GG) n end signal detected in the U2OS cell line, 38/818
in SK-MEL-2 and 46/594 in Saos-2. By contrast, we did
not observe any signal-free ends in over 5000 single-
molecule (TTAGGG) n tract measurements in the sen-
escing IMR90 cell line or the telomerase-positive cancer
cell lines UMUC3 and LNCaP [32]. The signal-free ends
are distributed unevenly across the arms analyzed for
U2OS and SK-MEL-2. Arms 3q, 8q, 14q, and 15q of
U2OS have 29 out of 57 signal-free ends (Table 1). 6q,
8p, 8q, 11q, and 14q of SK-MEL-2 have 23 out of 38
signal-free ends (Table 2). But for Saos-2, the signal-free
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Table 1 U2OS telomere lengths
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
1p 3.8 ± 4.4 (15) 1 4.4 ± 3.6 (4) 5 4 (3,1) 36 17.1
2p 2.1 ± 2.5 (12) 2 4.3 ± 4.7 (4) 2 5 (4,1) 30 10.7
3p 6.6 ± 8.4 (16) 0 2.9 ± 3.8 (7) 0 5 (1,4) 30 35.8
4p 3.2 ± 3.4 (19) 0 1.9 ± 2.1 (2) 1 7 (6,1) 14 11.8
5p 3.7 ± 4.2 (21) 3 0.1 ± 0.1 (9) 3 10 (1,9) 33 15.5
6p 2.8 ± 1.8 (8) 0 0.6 ± 1.1 (6) 0 6 (1,5) 43 6
7p 3.4 ± 7.0 (5) 0 0.5 ± 0.4 (17) 0 12 (3,9) 77 15.8
8p 2.7 ± 3.3 (8) 0 0.2 ± 0.2 (3) 0 6 (3,3) 28 8.4
9p 2.6 ± 4.9 (7) 2 4.7 ± 7.4 (5) 3 3 (2,1) 47 17.8
10p N/A N/A N/A N/A N/A N/A N/A
11p 4.4 ± 5.7 (12) 0 0.7 ± 0.1 (3) 10 1 (1,0) 52 18.1






18p 3.7 ± 5.1 (10) 1 0 3 1 (1,0) 21 16.6
19p 7.0 ± 8.1 (29) 1 3.2 ± 0 (1) 0 1 (1,0) 3 35.9






1q 3.4 ± 3.9 (6) 1 0.6 ± 0.6 (18) 4 8 (1,7) 76 9.4
2q 5.5 ± 6.1 (30) 0 1.1 ± 0 (1) 2 5 (5,0) 9 23.8
3q 0 (7) 7 0 16 0 70 N/A
4q N/A N/A N/A N/A N/A N/A N/A
5q 5.5 ± 5.6 (30) 0 6.6 ± 3.6 (3) 0 2 (2,0) 9 24.2
6q 7.8 ± 7.9 (21) 0 4.8 ± 1.5 (2) 0 2 (2,0) 9 28.2
7q 4.9 ± 4.4 (11) 0 7.9 ± 5.4 (2) 0 1 (1,0) 15 11.7
8q 1.8 ± 3.5 (23) 6 0.4 ± 0.3 (19) 7 15 (6,9) 52 12.9
9q 5.2 ± 5.3 (23) 0 3.3 ± 2.5 (6) 2 1 (1,0) 26 17.7
10q 3.8 ± 6.4 (2) 0 0 2 0 50 13.4
11q 4.2 ± 3.1 (7) 1 0.2 ± 0.2 (4) 1 4 (0,4) 38 8.5
12q 4.1 ± 4.7 (18) 4 0.7 ± 1.0 (7) 3 7 (3,4) 31 16.5
13q 5.5 ± 5.4 (30) 0 8.6 ± 5.8 (2) 0 1 (1,0) 6 20.9
14q 2.1 ± 4.8 (6) 10 0 4 0 20 16.7
15q 4.7 ± 5.7 (17) 6 0.4 ± 0.5 (3) 4 6 (4,2) 23 18.5
16q 5.3 ± 5.3 (28) 4 4.5 ± 4.2 (7) 0 4 (2,2) 18 17.1
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ends are distributed relatively evenly among the arms
(Table 3).
Fig. 1c shows several 15q ends of U2OS and 8p of SK-
MEL-2 which do not contain detectable (TTAGGG)n.
The blue stained DNA backbone extends beyond the
first two Nt.BspQI nicking sites without telomere label-
ing. We scored signal-free ends separately from the
(TTAGGG) n lengths acquired from ends with a detect-
able telomere signal, and did not include them in the
average (TTAGGG) n tract length calculations; note that
if we had, it would have impacted this metric signifi-
cantly for some telomeres (e.g., the average telomere
length for 15q would have decreased to 3.5 kb from 4.7
kb). Finally, specific subtelomeres (2p, 4p, 12q, 15q) of
U2OS have a relatively high number of short (TTAG
GG) n tracts amidst a few very long telomeres. An ex-
ample is shown in Fig. 1d with chromosome arm 2p.
Recombinant telomeres and ITSs were seen in three
ALT positive cell lines. U2OS has the highest fraction of
recombinant telomeres at the average of 24%; Saos-2 has
19%; SK-MEL-2 has the lowest fraction at only 11%. The
1q, 3q, 6p, 7p, 8q, 9p, 11p, 18q, 19q, and 21q arms of
U2OS have the highest fraction of recombinant telo-
meres. 1q, 3q, 9p, 18q, and 21q are shown to have high
fractions of recombinant telomeres in SK-MEL-2. In
Saos-2, 1p, 3q, 8q, 17q and 21q each have over 50% re-
combinant telomeres. The recombination partner DNA
fragment for most of these subtelomeres typically shows
a defined stable pattern (Fig. 2a). The 21q subtelomere
of U2OS shown in Fig. 2a has a combination of mole-
cules with end telomeres, recombination with retention
of ITS, and recombination without retention of ITS. The
21q arm telomeres retained ITS length (1.9 ± 4.0 kb) for
recombinant molecules is significantly shorter than the
end telomere length (5.3 ± 4.7 kb). The 21q arm of Saos-
2 is also highly recombined with similar average telo-
mere length (1.9 kb ± 0.7) in comparison to the end
telomere length (1.3 kb ± 0.6). The recombined patterns
of 21q are different between U2OS and Saos-2. Figure 2b
shows that 9p of U2OS has a defined recombination pat-
tern, while 7q of SK-MEL-2 lack defined patterns.).
Examples of very short ITSs at recombinant telomeres
are 1q, 6p, 7p, 11p, and 18q of U2OS, 20q of SK-MEL-2
and 3q of Saos-2, all with multiple detected internal telo-
meres averaging between 0.4 kb and about 1.3 kb. Overall,
recombinant molecules of U2OS have the highest fraction
of ITS loss (108 molecules with ITS loss compared to 182
molecules with ITS) among these three cell lines.
Chromosome 3q ends of U2OS had no detectable (TTAG
GG) n tracts at all, with 7 end molecules and 16 recom-
binant molecules all lacking telomere signal (Table 1). On
the other hand, SK-MEL-2 and Saos-2 have lower frac-
tions of ITS loss (5 vs. 82 of SK-MEL-2, and 3 vs. 118 of
Saos-2) compared to U2OS.
Figure 3 shows (TTAGGG) n telomere tract length
distributions for 19p, 18q, and 21q of U2OS, illustrating
the variability of this parameter depending upon the
subtelomere involved. Chromosome 19p ends are com-
prised almost exclusively of molecules with (TTAGGG)
n tracts, with long and heterogeneous tract lengths hav-
ing an overall average of 7.2 kb. Chromosome 18q ends
are mostly recombinant; the limited number of mole-
cules with end telomeres have very short (TTAGGG) n
tracts (0.9 kb ± 1.2), with 4 end molecules lacking any
signal. The ITSs associated with recombinant 18q mole-
cules are similarly short (0.9 kb ± 0.7) or absent (5 mole-
cules). The 21q subtelomere molecules have a broad
range of heterogeneously sized (TTAGGG) n tracts on
their ends with mostly very short or absent ITSs in re-
combinant telomeres.
From our previous single-molecule telomere length
analyses of senescing primary IMR90 fibroblasts and
cancer cell lines UMUC3 and LNCaP, we found that the
distribution of very short single telomeres was biased
Table 1 U2OS telomere lengths (Continued)
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
17q 5.4 ± 5.3 (30) 0 6.0 ± 5.9 (2) 3 4 (4,0) 14 18.2
18q 0.5 ± 1.2 (5) 4 0.9 ± 0.7 (26) 5 14 (2,12) 78 2.9
19q nd 1 1.5 ± 1.1 (25) 0 4 (0,4) 96 5
20q 3.4 ± 3.9 (21) 0 1.3 ± 1.1 (3) 0 6 (5,1) 13 14.2
21q 4.9 ± 4.7 (12) 1 1.9 ± 4.0 (13) 17 9 (1,8) 70 16.2
22q INP INP
Xq/Yq N/A N/A N/A N/A N/A N/A N/A
total 724 57 182 108 158 (65,93) 24
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Table 2 SK-MEL-2 telomere lengths
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
1p 4.5 ± 3.4 (24) 0 nd 0 1 (1,0) 0 12.2
2p 3.1 ± 4.1 (33) 2 nd 0 5 (5,0) 0 18.8
3p 4.2. ± 3.6 (28) 0 nd 0 5 (4,0) 0 14.6
4p 2.9 ± 3.2 (4) 0 nd 0 0 (0,0) 0 7.7
5p N/A N/A N/A N/A N/A N/A N/A
6p 2.1 ± 2.1 (13) 0 nd 0 1 (1,0) 0 7.5
7p 1.8 ± 2.0 (14) 2 nd 0 3 (3,0) 0 5.7
8p 2.9 ± 2.8 (31) 5 10.3 ± 0 (1) 0 5 (5,0) 3 11.7
9p 3.1 ± 3.2 (34) 1 2.6 ± 2.5 (5) 0 4 (4,0) 13 14.1
10p 3.2 ± 3.2 (26) 2 2.9 ± 0 (1) 0 2 (2,0) 4 11.2
11p N/A N/A N/A N/A N/A N/A N/A






18p 2.2 ± 2.6 (9) 1 1.1 ± 0 (1) 0 1 (1,0) 10 8.7
19p 2.7 ± 3.0 (32) 1 5.1 ± 3.9 (5) 0 4 (4,0) 14 13.2





1q 4.3 ± 3.6 (25) 1 3.9 ± 2.0 (5) 0 2 (2,0) 17 12
2q 2.5 ± 2.4 (30) 1 3.6 ± 1.1 (3) 0 3 (3,0) 9 8.6
3q nd 0 4.1 ± 9.2 (7) 4 1 (0,1) 100 24.9
4q N/A N/A N/A N/A N/A N/A N/A
5q 4.1 ± 3.3 (34) 0 2.4 ± 0 (1) 0 2 (2,0) 3 14.4
6q 3.3 ± 3.6 (24) 6 nd nd 0 (0,0) 0 13.8
7q 4.0 ± 8.0 (22) 2 4.7 ± 2.3 (6) 0 8 (7,1) 21 47.3
8q 4.0 ± 4.0 (28) 1 2.1 ± 0 (1) nd 1 (1,0) 0 12.9
9q 1.3 ± 2.0 (7) 4 nd 0 0 (0,0) 0 4.4
10q 3.6 ± 4.1 (20) 1 7.8 ± 6.8 (2) 0 2 (2,0) 9 13.6
11q 3.0 ± 4.7 (10) 4 nd 0 1 (1,0) 0 13.6
12q 4.9 ± 4.3 (31) 2 nd 0 3 (3,0) 0 13.7
13q 3.4 ± 2.8 (27) 3 nd 0 1 (1,0) 0 9.3
14q 1.7 ± 3.0 (23) 4 nd 0 8 (8,0) 0 14.3
15q 4.8 ± 3.5 (30) 1 nd 0 nd 0 14.3
16q 1.3 ± 1.1 (20) 2 4.4 ± 4.6 (4) 0 4 (4,0) 17 3.5
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with an unusually high fraction of very short telomeres
at 8q for all three cell lines, and also at 14q for IMR90
[32]. We therefore looked for unusual (TTAGGG) n
length distributions at these telomeres in the U2OS, SK-
MEL-2, and Saos-2 cancer cell lines. The typical single
molecule images with telomere tracts are shown in
Fig. 4a. For U2OS, 8q has relatively short (TTAGGG) n
tracts at 8q with the average length of 1.8 kb as shown
in Fig. 4b. The (TTAGGG) n tracts are highly variable,
ranging from 6 molecules featuring telomere loss, 6 ends
with detectable (TTAGGG) n lengths less than 500 bp,
and 11 end-molecules having a heterogeneous size dis-
tribution from 500 bp to 12.9 kb, with only 4 end mole-
cules having (TTAGGG) n tracts greater than 4 kb in
size (Table 1;Fig. 4b). For U2OS, 8q also has a high frac-
tion of recombinant ends, with 7 out of 26 of these mol-
ecules lacking ITSs and the remaining 19 recombinant
molecules averaging 0.4 kb-sized ITSs (Table 1, Fig. 4b).
Saos-2 8q behaves similarly to U2OS 8q. Besides very
short telomere ends (1.1 kb average telomere length),
Saos-2 8q also has a high fraction of recombinant ends,
but Saos-2 8q has fewer end telomere and ITS loss. SK-
MEL-2 8q seems to have a different profile compared to
U2OS and Saos-2 8q. It not only has longer end telo-
mere (4 kb average length), but also lacks recombinant
molecules.
Overall, the end telomere lengths of U2OS, SK-MEL-2, and
Saos-2 are highly variable ranging from undetectable to ex-
tremely long (Tables 1, 2, and 3) in comparison to UMUC3
and LNCaP which are documented to have relatively uniform
and short telomere length distributions [37, 38]. When look-
ing specifically at 8q ends, mean (TTAGGG) n tract lengths
are similar in the ALT-positive U2OS, SK-MEL-2 and Saos-2
cancer cell lines and telomerase-positive cancer cell lines. Few
very long telomeres are found at U2OS and SK-MEL-2 8q
distinguishing the ALT positive from the telomerase positive
cell lines at this telomere (Fig. 4b). On the other hand, Saos-2
completely lacks long telomeres with lower heterogeneity.
Similarly, 14q was enriched for short telomeres in
IMR90 [32]; in U2OS, 14q end-molecules had the high-
est fraction of signal-free ends (10/16 molecules) and all
4 recombined 14q ends lacked ITSs (Table 1). The aver-
age end telomere length of U2OS is at 1.6 kb. SK-MEL-2
14q also has short average telomere length of 1.7 kb with
only 4 molecules having end telomere loss. Saos-2 has
only one end telomere loss at 14q with relatively longer
average telomere length of 2.3 kb. The overall end telo-
mere length and heterogeneity is higher than in
telomerase-positive cancer cell lines. At some specific
ends lengths appear to be very similar, perhaps implying
a level of active cis control of the shortest telomeres in
both pre- and post-immortalization cells, irrespective of
TMM.
Telomeres with punctate (TTAGGG) n labeling pat-
terns were observed at many chromosome ends (ap-
proximately 65%) in all three ALT cell lines at nearly all
long extrachromosomal telomere repeat (ECTR) DNA
fragments (89%) using our single-molecule analysis
methods (Fig. 5). This punctate labeling feature was not
observed on any telomeres from IMR90 fibroblasts or
from telomerase-positive cell lines [32]. The punctate
feature of the labeling suggests stretches of nontelomeric
DNA sequence and/or variant (TTAGGG) n -like repeat
DNA interspersed with pure (TTAGGG) n in these telo-
mere tracts, as described previously [20, 39]. While
ECTR DNA including c-circles, t-circles, and small lin-
ear (TTAGGG) n fragments have long been known to
be closely associated with ALT-positive cells, with the
small linear ECTRs specifically found to be closely asso-
ciated with ALT-associated PML bodies [31, 40], it was
a surprise to discover the very large linear ECTRs using
our single-molecule analysis method (Fig. 5b). Large lin-
ear ECTRs comprised 40% of the total telomere signal in
Table 2 SK-MEL-2 telomere lengths (Continued)
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
17q 3.1 ± 4.3 (30) 2 4.8 ± 0 (1) 0 4 (4,0) 3 20.9
18q 3.9 ± 3.3 (31) 1 4.9 ± 3.0 (6) 0 2 (2,0) 16 12.3
19q 5.1 ± 5.4 (31) 0 2.6 ± 2.3 (2) 0 1 (1,0) 6 20.5
20q 1.6 ± 3.2 (12) 3 1.3 ± 1.3 (17) 1 12 (8,4) 59 16.5
21q 4.1 ± 3.8 (28) 0 5.1 ± 2.4 (4) 0 3 (3,0) 11 15.3
22q INP INP
Xq/Yq 1.2 ± 1.9 (16) 3 2.6 ± 1.3 (4) 0 3 (3,0) 20 7.5
Total 780 38 82 5 92 (87,5) 11
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Table 3 Saos-2 Telomere lengths
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
1p 4.8 ± 8.6 (14) 3 1.6 ± 1.8 (23) 3 5 (3,2) 62 30.5
2p 4.5 ± 3.5 (31) 1 nd 0 1 (1,0) 0 11.0
3p 7.5 ± 5.5 (30) 1 nd 0 1 (1,0) 0 25.5
4p 3.3 ± 2.7 (24) 2 nd 0 0 (0,0) 0 9.9
5p 5.9 ± 5.6 (14) 0 2.6 ± 1.6 (7) 0 0 (0,0) 41 18.3
6p 7.7 ± 7.6 (10) 1 3.1 ± 0 (1) 0 0 (0,0) 10 18.4
7p N/A N/A N/A N/A N/A N/A N/A
8p N/A N/A N/A N/A N/A N/A N/A
9p 4.7 ± 4.2 (17) 1 nd 0 0 (0,0) 0 13.6
10p 2.1 ± 1.7 (19) 2 nd 0 2 (2,0) 0 6.7
11p 5.3 ± 5.1 (7) 0 5.0 ± 5.8 (3) 0 0 (0,0) 30 11.8






18p 3.6 ± 3.0 (31) 0 1.1 ± 0 (1) 0 2 (2,0) 3 13.1
19p 4.1 ± 4.0 (30) 1 5.1 ± 3.9 (5) 0 4 (4,0) 13.2





1q 4.1 ± 4.6 (25) 3 2.9 ± 2.0 (4) 0 2 (2,0) 3 12.9
2q N/A N/A N/A N/A N/A N/A N/A
3q 0 ± 0 (1) 1 0.9 ± 0.6 (7) 0 3 (0,3) 88 1.8
4q 0.7 ± 0.9 (3) 1 nd 0 1 (1,0) 0 1.7
5q 5.7 ± 3.6 (27) 0 1.5 ± 0 (1) 0 0 (0,0) 4 12.4
6q 8.9 ± 10.0 (27) 2 14.5 ± 3.7 (5) 0 2 (2,0) 16 50
7q 1.9 ± 1.4 (27) 0 1.3 ± 0 (1) 0 2 (2,0) 4 6.1
8q 1.1 ± 0.7 (15) 1 1.4 ± 0.9 (18) 0 3 (3,0) 55 3.4
9q N/A N/A N/A N/A N/A N/A N/A
10q 3.0 ± 3.9 (30) 0 0.7 ± 0.9 (2) 0 2 (1,1) 15.9
11q N/A N/A N/A N/A N/A N/A N/A
12q N/A N/A N/A N/A N/A N/A N/A
13q 6.4 ± 6.2 (30) 1 7.6 ± 6.2 (5) 0 2 (2,0) 14 23.3
14q 2.3 ± 2.7 (26) 1 nd 0 5 (5,0) 0 6.3
15q N/A N/A N/A N/A N/A N/A N/A
16q 6.8 ± 17.7 (13) 2 nd 0 0 (0,0) 0 62.8
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U2OS; the average telomere length for these ECTRs was
11.0 kb with the longest measuring 50.4 kb. The exist-
ence and abundance of large linear ECTRs is a new
insight with potentially important ramifications for
mechanisms of DNA repair and telomere maintenance
at ALT telomeres, since they can potentially serve as
template molecules for long-tract break-induced repair
(BIR) to generate long stretches of new telomeric DNA
tracts at damaged telomeres. The same patterns of long
linear ECTRs are also observed in SK-MEL-2 and Saos-2
cell lines.
Discussion
Our general global observation of long end telomere
tracts and telomere length heterogeneity was anticipated
from prior studies of ALT cells [8]. However, the reso-
lution and subtelomere specificity of our single-molecule
analysis revealed many unanticipated details. First, aver-
age telomere tract length and heterogeneity level of end-
telomeres varied dramatically depending on the linked
subtelomere and the cell line, with a few subtelomeres
associated with mostly very short end telomeres, ends
lacking any telomere signal (“signal-free ends”), and
fused telomeres. Overall, there were a surprising number
of signal-free ends (8%) in U2OS cells and SK-MEL-2
cell lines (8%), and over half of these were associated
with just a few subtelomeres. On the other hand, the
signal-free ends are more evenly distributed across sub-
telomeres in Saos-2 cells (5%). By contrast, there were
no signal-free ends found in telomerase negative senes-
cing IMR90 fibroblasts, telomerase-positive cancer cell
lines (UMUC3, LNCaP) and lymphoblastoid cell lines
[32]. Second, there was a large fraction of recombinant
telomeres with variable tract lengths of internal
telomere-like sequence (ITS) that were retained at the
fusion junctions. As with the end-telomere characteris-
tics, features of the recombinant telomere molecules (in-
cluding the percentage of the specific subtelomere
molecules involved, and the relative size and retention of
the ITS at the fusion site) varied depending upon the
linked subtelomere and the cell line. Third, very large
linear ECTR molecules were present in all three ALT
positive cell lines; most of these (along with many large
end-telomere tracts) displayed punctate CRISPR/Cas9-
dependent (TTAGGG) n labeling patterns indicative of
interspersion of stretches of non-canonical telomere
repeats.
Ploidy changes, losses and gains of whole chromosomes,
and especially structural chromosome aberrations charac-
teristic of ALT cells are expected to be reflected in our re-
sults. Previous karyotypic analysis of ALT cell lines [41, 42]
revealed extensive genome rearrangement including hyper-
triploid and higher chromosome numbers as well as fre-
quent non-reciprocal translocations, deletions, and complex
chromosome rearrangements. These types of genome rear-
rangements are believed to be primarily a consequence of
telomere dysfunction [43, 44] and likely occurred in these
cells prior to immortalization by ALT, but there is also evi-
dence of ongoing, albeit lower frequency, genome instability
in immortalized ALT cells [41, 42]. In a study which in-
cluded U2OS and Saos-2 cell lines, clonal structural
chromosomal anomalies in the karyotypes of 9 ALT cell
lines was 3.7- fold higher than in telomerase-positive cancer
cell lines [42]. In the same study, approximately 45% of
telomere signals localized to structurally aberrant chromo-
some arms or to marker chromosomes. The low resolution
of the metaphase mapping precluded distinguishing telo-
mere capture events (which would stabilize the arm by
Table 3 Saos-2 Telomere lengths (Continued)
End telomere End telomere
loss













Mean Length (kb) ± Std (#
telomeres)




# molecules (# end,
# ITS)
Length (kb)
17q 1.6 ± 1.9 (10) 2 1.7 ± 2.5 (16) 0 4 (0,4) 62 10.1
18q 2.6 ± 3.4 (28) 4 nd 0 5 (5,0) 0 13.1
19q 5.1 ± 5.4 (31) 12 2.6 ± 2.3 (2) 0 1 (1,0) 20.5
20q N/A N/A N/A N/A N/A N/A N/A
21q 1.3 ± 0.6 (6) 1 1.9 ± 0.7 (22) 0 1 (1,0) 79 3.6
22q INP INP
Xq/Yq N/A N/A N/A N/A N/A N/A N/A
Total 548 46 118 3 52 (42,10) 19
N/A no data, not enough molecules to measure the telomere length
INP inverted nick pair (INP) sites
nr no reference sequences or significant gaps in the reference sequence
nd Not detected
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Fig. 1 (See legend on next page.)
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translocation of a large telomere-terminal chromosome
fragment, including the native subtelomere) from telomere
healing (direct addition of (TTAGGG) n sequences to a
broken chromosome). Internal telomere-like sequences (ex-
pected to result from the fusion of dysfunctional telomeres
with either other chromosome ends or with non-telomeric
genome sites; and also by other possible mechanisms [45])
were previously detected by metaphase FISH in the karyo-
types of many ALT cell lines, including U2OS and Saos-2
cells [42].
The types of large single-telomere-associated mole-
cules we analyzed can be explained in part in the context
of these types of clonal structural and numerical
chromosome changes in ALT. Molecules with end telo-
meres must arise from the original chromosome ends,
from telomere capture fragments translocated onto
broken chromosomes, or from internal chromosome
breaks healed by direct addition of (TTAGGG) n tracts.
In our dataset, only 70% of end-telomeres were linked to
recognizable subtelomeres (data not shown), suggesting
that a sizable fraction of end-telomeres may result from
telomere “healing” onto non-telomeric sites of chromo-
some breaks. The molecular correlates of ITS-generating
chromosome aberrations in our dataset are expected to
be recombinant telomere molecules with retained ITSs
sufficiently large enough for detection by metaphase
FISH. Recombinant telomere molecules with defined
partner molecules are expected to be clonal descendants
of telomere fusion events; those with multiple partners
must be subject to ongoing breakage and re-joining
events, perhaps similar in principle to yeast breakage-
fusion-bridge cycle events in which successive breakage
events preferentially localize to the original telomere fu-
sion sites and to pericentromeres [46, 47].
Recombinant telomeres linked to specific subtelomeres
were surprisingly fluid in their retention and tract length
variation of ITSs at the fusion site. For example, recom-
binant molecules linked to 21q in U2OS were associated
with the same partner genomic DNA fragment, yet single
molecules were found with the ITS retained, the ITS lost,
and ITSs with discrete sizes retained (Table 1, Fig. 2a). If
the entirety of these molecules are derived from a single
clonal precursor, then this result indicates ongoing evolu-
tion of the junction site (ITS length change, ITS loss, or
ITS gain) during U2OS propagation. For 3q in U2OS, all
examples of recombinant telomeres lack retention of ITS;
curiously, all examples of 3q-linked ends also lack telo-
mere signal (Table 1), perhaps suggesting the co-existence
of precursor 3q ends lacking telomeres and recombinant
3q in U2OS cultures. By contrast, in instances where re-
combinant telomere molecules from the same subtelo-
mere have multiple distinct partner fragments, the
simplest explanation is that there have been independent
recombination events involving the same subtelomere
locus suggesting the possibility that multiple breaks in
breakage-fusion-bridge cycles have occurred within the
telomere fusion sites, as has been observed in Sacharo-
myces cerevisiae [46, 47].
Subtelomeres we detected using our optical mapping
method in six other cell lines but which were rarely
found or not found in the dataset (4q, 8p, 10p, 10q, and
XqYq of U2OS; 5p, and 11p in SK-MEL-2; 2q, 7p, 8p,
9q, 11q, 12q, 15q, 20q and XqYq in Saos-2) may have
been associated with cycles of breakage and recombin-
ation that resulted in loss of their original sequence
organization. In this context, it is notable that two of
these subtelomeres, 4q and 10q, contain large tandem
arrays of 3.3 kb repeats (D4Z4) that are expected to de-
stabilize these subtelomeres in an environment of en-
hanced homologous recombination. Alternatively, some
of these missing or rearranged subtelomeres may have
suffered homozygous deletion in an early stage of the
crisis/immortalization process and were simply missing
in all subsequent generations of the cell line.
These results demonstrate the power and utility of our
single-molecule telomere analysis method for analyzing
ALT mechanisms providing new insight into structural
events associated with ALT telomeres and demonstrat-
ing subtelomere specific differences in these events. The
path is now open to a more detailed and directed
(See figure on previous page.)
Fig. 1 Chromosome arms with low recombination frequency. The hg38 subtelomere reference sequences are shown as light blue bars; the dark
blue vertical ticks within these bars indicate in silico Nt.BspQI nick-label sites. Individual single-molecule maps were de novo assembled into the
consensus maps (yellow lines), which were then aligned with the hg38 reference (light blue bars). The green lines on the consensus maps are
Nt.BspQI (GCTCTTC) sites that align to the corresponding reference site. Those that do not align with the reference are designated with light blue
lines. Chromosome arms without a consensus map were mapped to the hg38 reference instead of de novo assembled. The location of the
telomere is shown with a red “T”. Representative examples of raw images of single molecules that were imaged are shown below the references.
The DNA backbone is blue, and both the labeled subtelomeric Nt.BspQI sites and the telomere (TTAGGG) n tracts are green. a Representative
data for three chromosome arms (2q U2OS, 2p SK-MEL-2, 3p Saos-2) that have heterogenous end telomere length. b A 5q molecule from U2OS
with an end telomere and directly below, a 5q end recombined with an unknown genomic fragment with retention of a long internal telomere-
like sequence (ITS). 16q molecules from SK-MEL-2, one with recombination and one without. c Molecules of 15q from U2OS aligned to hg38; two
display end telomere (TTAGGG) n loss. Likewise, molecules from 8p SK-MEL-2, 1 displays telomere loss. d U2OS chromosome 2p molecules
aligned to hg38 with short end telomeres
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analyses of hypothesized mechanisms involved in ALT.
For example, subtelomere specificity of telomere length
regulation and stability may relate in part to TERRA
transcription [22–25]. TERRA is critical to telomere
length regulation and stability, transcribed from subtelo-
meric promoters, and differentially expressed at single
Fig. 2 Subtelomeres with a high fraction of recombinant molecules. The hg38 subtelomere reference sequences are shown as light blue bars;
the dark blue vertical ticks within these bars indicate in silico Nt.BspQI nick-label sites. The location of the telomere is shown with a red “T”.
Representative examples of raw images of single molecules that were imaged are shown below the references. The DNA backbone is blue, and
both the labeled subtelomeric Nt.BspQI sites and the telomere (TTAGGG) n tracts are green. a Chromosome 21q molecules with a defined
pattern in the recombination partner. The top U2OS molecule shows 21q with an end telomere. The second and third U2OS molecules are
examples of 21q end recombination with retention of an internal telomere-like sequence (ITS). The bottom two U2OS molecules show the same
recombination event but lack a detectible ITS. The top Saos-2 molecule shows 21q with an end telomere. b Chromosome 9p molecules from
U2OS without a defined pattern in the recombination partner. Chromosome 7q molecules from SK-MEL-2 without a defined pattern in the
recombination partner. Individual single-molecule maps were de novo assembled into the consensus maps (yellow lines), which were then
aligned with the hg38 reference (light blue bars). The green lines on the consensus maps are Nt.BspQI (GCTCTTC) sites that align to the
corresponding reference site. Those that do not align with the reference are designated with light blue lines. The top U2OS molecule shows a
structural variant of the 9p end with an end telomere. The bottom two U2OS molecules show the same structural variant of the 9p end
following recombination resulting in two distinct partner fragments, with retention of ITSs in both cases. Likewise the top 7q SK-MEL-2 molecule
has an end telomere while the bottom two show recombinants with ITS retention
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telomeres making it an attractive candidate for modulat-
ing single telomere specific features of ALT. There are
believed to be, as yet unknown, non-canonical recom-
bination and repair pathways involved in ALT [21, 31]
and our method of structural analysis could be key in
helping to sort these out. Different ALT conditions will
likely produce different categories and frequencies of
telomere structural events, and the methods demon-
strated here will provide a unique tool to track these at
the single-molecule and subtelomere-specific level.
Conclusions
By measuring (TTAGGG) n tract lengths from the same
large DNA molecules that were optically mapped, we
simultaneously analyzed telomere length dynamics and
subtelomere-linked structural changes at a large number
of specific subtelomeric loci in the ALT-positive cell
lines U2OS, SK-MEL-2 and Saos-2. Our results revealed
loci-specific ALT telomere features including terminal
(TTAGGG) n tract lengths and heterogeneity levels, the
frequencies of signal-free ends, the frequencies of re-
combinant telomeres and the presence/absence and size
of retained internal telomere-like sequences (ITSs) at
these telomere fusion junctions, and the presence of
large linear extrachromosomal telomere repeat (ECTR)
DNA molecules. All of these telomere-linked features
are dramatically distinct from previously characterized
somatic cell (IMR90) and telomerase-positive cancer cell
(UMUC3 and LNCaP) genomes we characterized previ-
ously using the same methodology (32). These results re-
veal in molecular detail the structural consequences of
telomere damage, repair and recombination mechanisms




The U-2 OS (ATTC® HTB-96™) Saos-2 (ATCC® HTB-
85™) and SK-MEL-2 (ATCC® HTB-68™) cell lines were
acquired from American Type Culture Collection
(ATCC). The U2OS cell line was cultured in McCoy’s 5a
Medium supplemented with 10% Fetal Bovine Serum
(FBS) (Corning). The Saos-2 cell line was cultured in
Fig. 3 End telomere lengths and retained ITSs at specific recombined telomeres. Telomere (TTAGGG) n tract length results for 19p, 18q, and 21q
from U2OS. Each single molecule telomere length measurement is represented by a dot and the average telomere length for each chromosome
arm is shown as a horizontal line. For each chromosome arm, the left group of dots is from telomere end molecules. The total number of
molecules is reported below with the number of molecules with complete telomere tract loss in parentheses. The right group of dots is from
molecules with recombined telomere ends. The total number of recombined molecules is reported below with the number of recombined end
molecules lacking retention of a detectable (TTAGGG) n tract indicated in parentheses
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McCoy’s 5a Medium supplemented with 15% FBS. The
SK-MEL-2 cell line was cultured in Eagle’s Minimum
Essential Medium supplemented with 10% FBS. The
cells were passaged using 0.25% trypsin-EDTA (Gibco).
High molecular weight DNA extraction, guide RNA
preparation and the two color DNA labeling scheme:
These procedures are followed exactly as described in
McCaffrey et al. [32].
DNA loading and imaging
After nick-labeling, the samples were treated with Prote-
ase and IrysPrep Stop Solution (BioNano Genomics)
[32]. The labeled DNA was stained with YOYO-1 (Invi-
trogen), and was loaded into the nanochannels following
the established protocol [33]. We generally collected 60x
coverage (180Gb) data to obtain 30 molecules containing
the telomeres for each chromosome. The image analysis
was done following the established procedure [32].
De novo genome map assembly
Single DNA molecules were assembled de novo into
consensus maps or aligned to hg38 reference using
software tools developed at BioNano Genomics, spe-
cifically Refaligner and Assembler [48]. The de novo
assembly procedure is the same as described in
McCaffrey et al. [32].
Telomere length analysis
The telomere labels were found to be the extra labels at
the end of molecules or in the middle of recombinant
molecules. The length of the telomeres was inferred
from its fluorescent label intensity following the estab-
lished protocols [32].
(See figure on previous page.)
Fig. 4 Comparison of 8q for U2OS, UMUC3, and LNCaP. a The hg38 subtelomere reference sequence for 8q is shown as a light blue bar; the dark
blue vertical ticks within this bar indicate in silico Nt.BspQI nick-label sites. The location of the telomere is shown with a red “T”. Representative
examples of raw images of single molecules that were imaged are shown below the reference for each of the cell lines. The DNA backbone is
blue, and both the labeled subtelomeric Nt.BspQI sites and the telomere (TTAGGG) n tracts are green. The top U2OS molecule has an end
telomere with a (TTAGGG) n tract, the second has undergone recombination with retention of an ITS, telomere, the third has undergone
recombination without retention of an ITS, and the bottom molecule has an end telomere loss. The Saos-2 molecules retain their ITS., but SK-
MEL-2 has only one ITS. b Comparison of U2OS, Saos-2 and SK-MEL-2 end telomeres and internal telomere length with UMUC3 and LNCaP end
telomere length. Each single molecule telomere length measurement is represented by a dot and the average telomere length for each
chromosome arm is shown as a horizontal line. UMUC3 and LNCap don’t have any ITS due to recombination
Fig. 5 Punctate and Extrachromosomal Telomeres. Representative examples of raw images with the DNA backbone blue, and both the labeled
subtelomeric Nt.BspQI sites and the telomere (TTAGGG) n tracts are green. a Examples of end telomeres with punctate (TTAGGG) n tracts. The
intensity of these telomere tracts is decreased and shown below the full molecule. b Examples of Extrachromosomal telomeres, many of which
display punctate (TTAGGG) n tracts
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ALT: Alternative Lengthening of Telomeres; BIR: Break-induced repair;
DDR: DNA Damage Response; ECTR: Extrachromosomal telomere repeat;
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